Biểu đồ giá cổ phiếu ALVO
ALVO Thu nhập
Alvotech SA
$3.26
1.87%
$0.05
Khi đóng cửa: May 08, 16:00:00 GMT-4
$3.4
4.29%
$0.14
Phiên trước giờ: May 11, 09:11:35 GMT-4
Quay lại
Alvotech SA (ALVO) Thu nhập
Thống kê chính
Giá đóng cửa trước
$3.2
Giá mở cửa
$3.21
Phạm vi ngày
$3.17 - $3.4
Phạm vi 52 tuần
$3.03 - $11.85
Khối lượng
469.9K
Khối lượng trung bình
535.2K
Tỷ suất cổ tức
--
EPS (TTM)
0.05
Vốn hóa thị trường
$1.0B
ALVO là gì?
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focused on the development and manufacture of biosimilar medicines for patients globally. The company is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). The company has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.
